FDA Orange Book · active-ingredient family
Hydrochlorothiazide; propranolol hydrochloride
Hydrochlorothiazide; propranolol hydrochloride is approved as 2 brand and 17 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:INDERIDE-40/25 · NDA 018031
2
Brand (NDA)
17
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, extended release, tablet
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| INDERIDE-40/25RLD×2 | WYETH PHARMS INC | NDA 018031 | — | Approved Prior to Jan 1, 1982 | |
| INDERIDE LA 120/50×3 | WYETH AYERST | NDA 019059 | — | Jul 03, 1985 |
Generic (ANDA) products (17)
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Hydrochlorothiazide; propranolol hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

